SARS-CoV-2 serology in HIV PrEP users during the COVID-19 pandemic: THE PREP-CO STUDY

To investigate to prevalence and seroconversion rate of SARS-CoV-2 antibodies in a German cohort of MSM using HIV PrEP, Germany, over a time period of one year following the first outbreak of the covid pandemic.

DRKS link

Overview of SARS-COV-2 studies seroprevalence in context of the worldwide  COVID-19 pandemie. You can register a study here: Contribute
@serohub on Twitter
hzi-braunschweig/serohub on GitHub